-+ 0.00%
-+ 0.00%
-+ 0.00%

AKEBIA THERAPEUTICS ANNOUNCES INITIATION OF A PHASE 2 BASKET TRIAL TO STUDY EBRIBAFUSP, A NEXT-GENERATION COMPLEMENT INHIBITOR IN RARE KIDNEY DISEASES

路透·08/03/2026 12:00:01

登录查看新闻详情